πŸ‡ΊπŸ‡Έ FDA
Patent

US 8173635

Kinase inhibitors

granted A61PA61P1/00A61P11/06

Quick answer

US patent 8173635 (Kinase inhibitors) held by Vertex Pharmaceuticals Incorporated expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue May 08 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
29
CPC classes
A61P, A61P1/00, A61P11/06, A61P17/06, A61P19/02